EI
ONC

Ethic Inc’s BeOne Medicines Ltd ONC Stock Holding History

Ethic Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-953
Closed -$325K – 1284
2025
Q3 		$325K Buy
+953
New +$289K 0.01% 980

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Ethic Inc's ONC Position: Q4 2025 in Review

Ethic Inc sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 953 shares — an estimated $325K sold.

Ethic Inc first reported a position in ONC in Q3 2025 and held it in 1 quarter. The position peaked at $325K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Ethic Inc reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Ethic Inc sold 953 BeOne Medicines Ltd shares in Q4 2025, an estimated $325K.
  • Ethic Inc first reported a position in BeOne Medicines Ltd in Q3 2025 and held it in 1 quarter.
  • Ethic Inc's BeOne Medicines Ltd position peaked at $325K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Ethic Inc's 13F filing for Q4 2025, filed 3 Feb 2026.